The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glucagon-Global Market Insights and Sales Trends 2025
Synopsis
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The global Glucagon market size is expected to reach US$ 845.7 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Glucagon in various end use industries. The expanding demands from the Emergency Kits, General Use, Diagnostic & Motility and Cardiogenic Shock, are propelling Glucagon market. Inject Glucagon, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nasal Glucagon segment is estimated at % CAGR for the next seven-year period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glucagon market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glucagon market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glucagon sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glucagon covered in this report include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
The global Glucagon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Global Glucagon market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glucagon market, Segment by Type:
Inject Glucagon
Nasal Glucagon
Global Glucagon market, by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The global Glucagon market size is expected to reach US$ 845.7 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Glucagon in various end use industries. The expanding demands from the Emergency Kits, General Use, Diagnostic & Motility and Cardiogenic Shock, are propelling Glucagon market. Inject Glucagon, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nasal Glucagon segment is estimated at % CAGR for the next seven-year period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glucagon market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glucagon market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glucagon sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glucagon covered in this report include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
The global Glucagon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Global Glucagon market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glucagon market, Segment by Type:
Inject Glucagon
Nasal Glucagon
Global Glucagon market, by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Glucagon Market Overview
1.1 Glucagon Product Overview
1.2 Glucagon Market Segment by Type
1.2.1 Inject Glucagon
1.2.2 Nasal Glucagon
1.3 Global Glucagon Market Size by Type
1.3.1 Global Glucagon Market Size Overview by Type (2018-2029)
1.3.2 Global Glucagon Historic Market Size Review by Type (2018-2023)
1.3.3 Global Glucagon Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glucagon Sales Breakdown by Type (2018-2023)
1.4.2 Europe Glucagon Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Glucagon Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Glucagon Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Glucagon Sales Breakdown by Type (2018-2023)
2 Global Glucagon Market Competition by Company
2.1 Global Top Players by Glucagon Sales (2018-2023)
2.2 Global Top Players by Glucagon Revenue (2018-2023)
2.3 Global Top Players by Glucagon Price (2018-2023)
2.4 Global Top Manufacturers Glucagon Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glucagon Market Competitive Situation and Trends
2.5.1 Glucagon Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Glucagon Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon as of 2022)
2.7 Date of Key Manufacturers Enter into Glucagon Market
2.8 Key Manufacturers Glucagon Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glucagon Status and Outlook by Region
3.1 Global Glucagon Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Glucagon Historic Market Size by Region
3.2.1 Global Glucagon Sales in Volume by Region (2018-2023)
3.2.2 Global Glucagon Sales in Value by Region (2018-2023)
3.2.3 Global Glucagon Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Glucagon Forecasted Market Size by Region
3.3.1 Global Glucagon Sales in Volume by Region (2024-2029)
3.3.2 Global Glucagon Sales in Value by Region (2024-2029)
3.3.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Glucagon by Application
4.1 Glucagon Market Segment by Application
4.1.1 Emergency Kits
4.1.2 General Use
4.1.3 Diagnostic & Motility
4.1.4 Cardiogenic Shock
4.1.5 Others
4.2 Global Glucagon Market Size by Application
4.2.1 Global Glucagon Market Size Overview by Application (2018-2029)
4.2.2 Global Glucagon Historic Market Size Review by Application (2018-2023)
4.2.3 Global Glucagon Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glucagon Sales Breakdown by Application (2018-2023)
4.3.2 Europe Glucagon Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Glucagon Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Glucagon Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Glucagon Sales Breakdown by Application (2018-2023)
5 North America Glucagon by Country
5.1 North America Glucagon Historic Market Size by Country
5.1.1 North America Glucagon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Glucagon Sales in Volume by Country (2018-2023)
5.1.3 North America Glucagon Sales in Value by Country (2018-2023)
5.2 North America Glucagon Forecasted Market Size by Country
5.2.1 North America Glucagon Sales in Volume by Country (2024-2029)
5.2.2 North America Glucagon Sales in Value by Country (2024-2029)
6 Europe Glucagon by Country
6.1 Europe Glucagon Historic Market Size by Country
6.1.1 Europe Glucagon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Glucagon Sales in Volume by Country (2018-2023)
6.1.3 Europe Glucagon Sales in Value by Country (2018-2023)
6.2 Europe Glucagon Forecasted Market Size by Country
6.2.1 Europe Glucagon Sales in Volume by Country (2024-2029)
6.2.2 Europe Glucagon Sales in Value by Country (2024-2029)
7 Asia-Pacific Glucagon by Region
7.1 Asia-Pacific Glucagon Historic Market Size by Region
7.1.1 Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Glucagon Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Glucagon Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Glucagon Forecasted Market Size by Region
7.2.1 Asia-Pacific Glucagon Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Glucagon Sales in Value by Region (2024-2029)
8 Latin America Glucagon by Country
8.1 Latin America Glucagon Historic Market Size by Country
8.1.1 Latin America Glucagon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Glucagon Sales in Volume by Country (2018-2023)
8.1.3 Latin America Glucagon Sales in Value by Country (2018-2023)
8.2 Latin America Glucagon Forecasted Market Size by Country
8.2.1 Latin America Glucagon Sales in Volume by Country (2024-2029)
8.2.2 Latin America Glucagon Sales in Value by Country (2024-2029)
9 Middle East and Africa Glucagon by Country
9.1 Middle East and Africa Glucagon Historic Market Size by Country
9.1.1 Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Glucagon Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Glucagon Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Glucagon Forecasted Market Size by Country
9.2.1 Middle East and Africa Glucagon Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Glucagon Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Glucagon Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Glucagon Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Glucagon Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Torrent Labs
10.4.1 Torrent Labs Company Information
10.4.2 Torrent Labs Introduction and Business Overview
10.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Torrent Labs Glucagon Products Offered
10.4.5 Torrent Labs Recent Development
10.5 Taj Pharmaceuticals
10.5.1 Taj Pharmaceuticals Company Information
10.5.2 Taj Pharmaceuticals Introduction and Business Overview
10.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Taj Pharmaceuticals Glucagon Products Offered
10.5.5 Taj Pharmaceuticals Recent Development
10.6 Xeris Pharmaceuticals
10.6.1 Xeris Pharmaceuticals Company Information
10.6.2 Xeris Pharmaceuticals Introduction and Business Overview
10.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Xeris Pharmaceuticals Glucagon Products Offered
10.6.5 Xeris Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glucagon Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glucagon Industrial Chain Analysis
11.4 Glucagon Market Dynamics
11.4.1 Glucagon Industry Trends
11.4.2 Glucagon Market Drivers
11.4.3 Glucagon Market Challenges
11.4.4 Glucagon Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glucagon Distributors
12.3 Glucagon Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
